Positioning and Outlook - 2026-10-29
Published 2026-10-29
A general, impersonal research note on a rules-based model portfolio. Not personalized investment advice; see the disclosures at the end.
Recent Events
The Federal Reserve held rates steady at its late-October meeting, though two officials dissented in favor of another increase, a split that framed the policy backdrop as credit conditions were already drawing closer scrutiny. High-yield spreads widened over the same stretch, and the share of companies flagged as financially strained edged higher, with the average credit-survival reading slipping a point week over week. Oil prices climbed after an attack on a Saudi Arabian refinery revived supply concerns, while the corporate tape carried a steady flow of earnings and material-agreement filings alongside routine market commentary. The days since also brought Fed speeches on supervisory modernization and the signaling value of economic projections, threads the outlook section picks up from here.
Macro and policy:
2026-10-28 — Markets: Fed Holds Rates Steady but Two Officials Sought Another Increase.
2026-10-28 — Markets: Oil prices rise after attack on Saudi Arabian refinery reignites supply concerns.
2026-10-28 — Fed official remarks: cook: dissent_vote.
2026-10-28 — Fed official remarks: hammack: dissent_vote.
Credit and corporate:
2026-10-29 — High-yield credit spreads: HY OAS Weekly: WIDENING → hold cash.
2026-10-29 — Corporate buybacks: Buybacks: 13742 active, $4577B TTM.
2026-10-29 — Corporate credit health: Credit survival: avg 47/100, 8173 in danger (22.5%, above) [scorer 2026-10-13], Altman basis: 82% measured, 14% model-N/A, 4% data gap.
2026-10-22 — Corporate credit health: Credit survival: avg 48/100, 7944 in danger, Altman basis: 84% measured, 13% model-N/A, 3% data gap.
On the calendar:
2026-10-15 — Central bank: Bowman, Supervisory Modernization After Silicon Valley Bank.
2026-10-08 — Central bank: Waller, The Signaling Value of the Summary of Economic Projections.
Notable news:
2026-10-29 — Company news: Energy & Utilities Roundup: Market Talk.
2026-10-28 — Company news: 8-K Entry into Material Agreement; Regulation FD Disclosure (2026-10-28).
2026-10-28 — Company news: 8-K (2026-10-28).
2026-10-28 — Company news: 8-K Results of Operations (Earnings) (2026-10-28).
Looking back at our own projection: An earlier projection (dated 2026-10-29) called for a improving near-term tape, but the realized move could not be measured here against a broad-market proxy, so this issue does not score it.
Upcoming Events
The calendar ahead is dominated by a dense run of central-bank decisions, with the Federal Reserve, European Central Bank and Bank of Japan all meeting within three days of one another in late October, followed by the Bank of England in early November. That clustering leaves little breathing room between policy signals, and it coincides with a heavy US data slate as GDP and personal income and outlays land on the same day. Away from the macro spine, the window also carries a steady stream of corporate earnings and a handful of mid-stage drug trial readouts, while the People's Bank of China's loan prime rate fixing rounds out the schedule in mid-November.
2026-10-28 (US): FOMC monetary policy decision — high expected impact.
2026-10-29 (EZ): ECB Governing Council monetary policy meeting — high expected impact.
2026-10-30 (JP): Bank of Japan Monetary Policy Meeting — high expected impact.
2026-11-05 (UK): Bank of England MPC monetary policy decision — high expected impact.
2026-11-20 (CN): PBOC Loan Prime Rate (LPR) fixing.
Other scheduled catalysts to watch:
2026-10-28: phase3 readout: RO7204239 (RHHBY) (moderate expected impact).
2026-10-28: 17-Week BILL auction (moderate expected impact).
2026-10-28: 2-Year NOTE auction (moderate expected impact).
2026-10-28: phase3 readout: Belzutifan (MRK) (moderate expected impact).
2026-10-29: Gross Domestic Product (GDP) release (high expected impact).
2026-10-29: Personal Income & Outlays (PCE) release (high expected impact).
2026-10-29: phase3 readout: Ianalumab (NVS) (moderate expected impact).
Corporate earnings calendar: 2118 reports scheduled in the window, the nearest including MDXG (2026-10-28), LCII (2026-10-28), CNMD (2026-10-28), EXP (2026-10-28), CWK (2026-10-28), CWT (2026-10-28).
Macro Projections
The near-term calendar is dense with catalysts that each test a different link in the chain: the Bank of Japan meets on 2026-10-30 as the first event for yen carry and long Japanese government bond duration, ARES and APO report on 11/2–3 as a check on private-credit and risk-financing conditions, and the Bank of England on 11/5, payrolls on 11/6 and CPI on 11/10 then test whether the hawkish-hold path holds or energy inflation forces a repricing. The honest reading of carry stress is that it is receding but not resolved, the carry model puts a disorderly unwind at 30.0%, flat on the latest step but down from 39.8% in its trail, while slow-motion crack sits at 31.4%, and the credit channel is doing the improving, with the CCC/BB measure falling 1.59 points to 1.92 on 9/30 from 3.51 prior and high-yield spreads (HY OAS) tightening to 3.18% on 10/27 from 3.40% on 10/22. The Fed's intervention propensity at 26.0% (down 0.35 points) and hold propensity at 77.8%, alongside a kernel reading of 45/100 for HOLD, say the confirmation is still incomplete, and cross-asset evidence broadly agrees with the improvement: VIX at 17.52, MOVE at 94.55bp and G7 FX volatility (how much the major-currency exchange rates are swinging) with a reading of -0.538 are all decelerating, VIX/VIX3M at 0.895 sits in contango, yet SKEW at 149.22 still shows a fat-left-tail bid. The sovereign move behind all this is US-specific rather than synchronised, the 30Y Treasury at 5.361% sits at its 95.4th historical percentile and was last higher on 10/21, the 10Y at 5.045% is only at its 62.2nd, the 2Y holds at 4.68%, while Bunds at 3.371%, JGBs at 2.829% and gilts at 5.305% (down 6.9bp on the week) do not join the rise, and UST–JGB and UST–Bund 10Y spreads widened 15.5 and 12.6bp to 2.216% and 1.674%. That relative calm diverges sharply from the geopolitical backdrop, GPR at 165.2 on 10/26 with Iran/Hormuz near closure, an escalating Russia–Ukraine war, kinetic Israel–Gaza fighting, spiking Houthi/Red Sea insurance and elevated Taiwan drills, and from the structural horizon, where developed ex-US earnings yields at 5.82% and EM at 6.98% tower over the US at 4.13%, a US CAPE of 40.9 and a 2.45% implied real return leave little cushion, and a 20% Kalshi recession probability for 2027 sits five points below my 25%. The fork is explicit: roughly 30% goes to a calm-credit break by 2027-03-31, led by HY OAS above 4.00% together with MOVE above 120bp; if Brent is above $110.50 on 11/10, renewed hike pricing, a 30Y push toward 5.50% and energy over long duration follow, while otherwise muddle-through extends and HY OAS below 3.00% by 11/28 confirms a carry/ex-US tilt, this chain falsifies on sustained HY OAS above 4% with VIX/VIX3M at or above 1 before 11/28, or a 30Y below 5.10% with narrowing US–foreign spreads by 2027-01-27.
The BoJ on 2026-10-30 is the first catalyst for yen carry and JGB duration; ARES/APO earnings on 11/2–3 test private-credit and risk financing; the BoE on 11/5, payrolls on 11/6 and CPI on 11/10 then test the hawkish-hold/energy-inflation fork. Carry stress is receding, not gone: the carry model puts disorderly unwind at 30.0%, flat on the last step but down from 39.8% in its trail (decelerating_negative), while slow-motion crack remains 31.4%. The credit model’s CCC/BB z36 is accelerating_negative at 1.92 on 9/30 versus 3.51 prior, a 1.59-point drop, and observed HY OAS tightened to 3.18% on 10/27 from 3.40% on 10/22. The Fed model’s intervention propensity is 26.0%, down 0.35 percentage points and accelerating_negative; hold propensity is 77.8%. The kernel’s 45/100 HOLD says confirmation remains incomplete. The latest sovereign move is US-specific, not synchronised. UST 30Y is 5.361% and 10Y 5.045%, both accelerating_positive; the 30Y sits at its 95.4th historical percentile and was last higher on 10/21, versus only the 62.2nd percentile for the 10Y, while the 2Y is 4.68% and stable. By contrast, Bund 10Y is 3.371% (accelerating_negative), JGB 10Y 2.829% (decelerating_negative), and gilt 10Y 5.305% (stable, down 6.9bp weekly). Foreign long ends remain historically extreme without joining this week’s US rise: JGB 30Y is 3.895%, stable and at its 98.8th percentile; gilt 20Y is 5.596%, stable and at its 99.0th. UST–JGB and UST–Bund 10Y spreads widened 15.5/12.6bp to 2.216/1.674%. Cross-asset evidence agrees with the carry/credit improvement: VIX 17.52 and MOVE 94.55bp are both accelerating_negative, G7 FX-vol z is -0.538 and accelerating_negative, and VIX/VIX3M at 0.895 is contango. But SKEW 149.22, also accelerating_negative, still shows a fat-left-tail bid. That relative calm diverges from GPR 165.2 on 10/26 and Iran/Hormuz near closure. Russia–Ukraine is escalating, Israel–Gaza kinetic, Houthi/Red Sea insurance spiking, Taiwan drills elevated, and US–China tech/North Korea pre-crisis; sovereign-distress flags cover Egypt, Indonesia, Japan, Brazil and Korea. WSJ reports oil slipping after a higher settle as Vance outreach competes with Trump’s threat to restart war; Al Jazeera reports Iranian red lines and a Chinese envoy. German confidence at -30.8 shows energy transmission, while Reuters’ AI-funding scrutiny and SAP’s cheaper-model shift challenge the US concentration trade. The 10Y breakeven is 2.35%, accelerating_positive but unchanged weekly, not full closure-inflation pricing. I assign roughly 30% to a calm-credit break by 2027-03-31; lead indicators are HY OAS above 4.00% together with MOVE above 120bp. If Brent is above $110.50 on 11/10, expect renewed hike pricing, a 30Y push toward 5.50%, and energy over long duration; else, muddle-through extends, with HY OAS below 3.00% by 11/28 confirming a carry/ex-US tilt. Cross-region earnings yields favour developed ex-US at 5.82% and EM at 6.98% over the US at 4.13%; US CAPE 40.9 and 2.45% implied real return offer little cushion. Kalshi prices 2027 recession at 20% versus my 25%, five points of underpriced tail, with October payrolls above 70,000 priced at only 47%, but Q4 GDP above 2% at 61% argues against imminent collapse. Tier-3 mild greed at 64 merely confirms, and cannot override, Tier-1 market evidence. Falsification: sustained HY OAS above 4% and VIX/VIX3M at or above 1 (backwardation) before 11/28, or a 30Y below 5.10% with narrowing US–foreign spreads by 2027-01-27.
Positioning
Position weights are set to scale with conviction, with each holding sized from its screening-kernel composite score, a modelled blend of expected upside drift against drawdown probability, so the highest-scoring names carry the largest equity weights while the weakest stay small. Behind those positions sit structural mechanisms, each a documented cause-and-effect channel carried with its historical base rate across every prior firing and discounted for what the market already prices; they are weighable inputs rather than predictions or guarantees. Those mechanisms calibrate the overall risk appetite, and the holdings themselves, led by the highest-conviction names, are set out in the model-portfolio table below.
The model is positioned into a elevated credit regime, with high-yield credit spreads near 3.18%.
Position weights scale to conviction: each name is sized from its screening-kernel composite score (a modelled blend of expected upside drift against drawdown probability), so the highest-scoring names take the largest equity weights while low-conviction names stay small. The strongest-scoring holdings are ET (composite 2.66, 4.3% modelled 3m upside drift), CCJ (composite 2.30, -0.5% modelled 3m upside drift), NTR (composite 2.28, 3.5% modelled 3m upside drift). Every holding's weight and the dossier behind it are set out in the model-portfolio table below.
Structural mechanisms behind the positioning — each a documented cause-and-effect channel carried with its honest historical base rate over every prior firing (hit rate, misses counted) and discounted by what the market already prices. They are weighable inputs, not predictions or guarantees:
op:china-ai-narrative-threat-v2: historically associated with an upside move in the affected asset (fired 1 times, base rate 100%, 0 misses).
op:hormuz-buffer-ratchet-v2: historically associated with an upside move in the affected asset (fired 1 times, base rate 100%, 0 misses).
op:trump-policy-reaction-function-v1: historically associated with an upside move in the affected asset (fired 1 times, base rate 100%, 0 misses).
Model Portfolio
The model portfolio holds a substantial cash reserve, with roughly two-fifths parked in money-market exposure as dry powder reserved for staged deployment as the credit and volatility picture resolves. The deployed capital splits into two structural sleeves: a meaningful inflation-linked Treasury position spread across three maturities, built around the financial-repression thesis on suppressed real rates, and a smaller gold allocation serving as a geopolitical flight-to-quality and monetary-stress diversifier. Alongside these sits a quality-factor equity sleeve tilted to the AI capex cycle, complemented by a midstream energy infrastructure holding.
| Name | % | Description & deep-dive |
|---|---|---|
| Money Market | 40.8% | Money-market / cash exposure: dry powder held for staged deployment into the cascade as the credit and volatility picture resolves. It is positioned against a elevated credit regime, with high-yield credit spreads near 3.18%, the live macro backdrop the model reads today. |
| SCHP | 12.5% | Inflation-linked Treasuries exposure: inflation-linked real-yield exposure against the financial-repression thesis (real assets favoured when real rates are suppressed). The structural rationale rests on a documented mechanism (base rate 86% over 7 prior firings, 1 miss counted, roughly 60% already priced). It is positioned against a elevated credit regime, with high-yield credit spreads near 3.18%, the live macro backdrop the model reads today. |
| QUAL | 11.4% | Global quality equity exposure: quality-factor equity exposure (high return-on-capital, low leverage) tilted to the AI capex cycle. It is positioned against a elevated credit regime, with high-yield credit spreads near 3.18%, the live macro backdrop the model reads today. |
| VTIP | 7.7% | Inflation-linked Treasuries exposure: inflation-linked real-yield exposure against the financial-repression thesis (real assets favoured when real rates are suppressed). The structural rationale rests on a documented mechanism (base rate 86% over 7 prior firings, 1 miss counted, roughly 60% already priced). It is positioned against a elevated credit regime, with high-yield credit spreads near 3.18%, the live macro backdrop the model reads today. |
| LTPZ | 5.8% | Inflation-linked Treasuries exposure: inflation-linked real-yield exposure against the financial-repression thesis (real assets favoured when real rates are suppressed). The structural rationale rests on a documented mechanism (base rate 86% over 7 prior firings, 1 miss counted, roughly 60% already priced). It is positioned against a elevated credit regime, with high-yield credit spreads near 3.18%, the live macro backdrop the model reads today. |
| KMI | 5.0% | Kinder Morgan is a midstream energy infrastructure company with regulated pipeline and terminal assets.. |
| IAU | 4.8% | Gold / precious-metals exposure: a documented geopolitical-risk to flight-to-quality channel into gold, plus a monetary-stress diversifier role. The structural rationale rests on a documented mechanism (base rate 32% over 63 prior firings, 43 misses counted, roughly 50% already priced). It is positioned against a elevated credit regime, with high-yield credit spreads near 3.18%, the live macro backdrop the model reads today. |
| GDX | 1.9% | Gold / precious-metals exposure: a documented geopolitical-risk to flight-to-quality channel into gold, plus a monetary-stress diversifier role. The structural rationale rests on a documented mechanism (base rate 32% over 63 prior firings, 43 misses counted, roughly 50% already priced). It is positioned against a elevated credit regime, with high-yield credit spreads near 3.18%, the live macro backdrop the model reads today. |
| LDOS | 1.9% | Leidos is a U.S. government contractor providing technology services in defense, intelligence, and health markets.. |
| SPY | 1.8% | Class 1 (deploy/hold): RATIFY the composed book. Deployment is continuous, not a binary macro call: SPY is a small measured add, SGOV/QUAL/SCHP are scaled as composed, and no new candidate is promoted. Class 2 (asset selection): stay inside the composed universe; the candidates are evaluated but not held because their scoring records have not yet granted sizing authority. Class 3 (position management): exit falsified MP and the residual ET position, while preserving the reserve and the real-carr. It is positioned against a elevated credit regime, with high-yield credit spreads near 3.18%. |
| FCX | 1.4% | Global copper miner exposed to commodity price cycles and operational risks in Indonesia. Technically the name sits in Weinstein stage 2. Factor exposures lean toward value +1.86, quality -1.63, growth +0.84. Research sentiment reads neutral. |
| SCCO | 1.3% | Bull case: Structural copper demand from electrification, renewable energy, and AI data centers supports long-term price appreciation; SCCO's industry-leading margins (gross margin ~59%, operating margin ~58%) and low cash costs provide a wide moat; the Tía María project and strong free cash flow generation (FCF margin ~29%) offer additional upside if copper prices remain elevated and the US-Iran peace deal temporarily eases inflation fears, potentially lowering the dollar. Bear case: The stock trades at a significant premium to its sector (P/E 29.2 vs. peer median 26.1; P/B 12.3 vs. 2.2) with a consensus analyst target ~15% below current price and a majority of sell/underperform ratings; a potential copper demand slowdown from China's economic struggles or renewed trade war escalation, combined with a hawkish Fed holding rates high for longer, could compress multiples and trigger a sharp correction. Additionally, the recent Iran peace deal may reduce the 'lower-correlation' premium that had supported commodity currencies and metals. Key risks include Severe valuation overhang: SCCO is priced for perfection, leaving no margin of safety if copper prices retreat or costs rise.; Geopolitical and regulatory risks in Peru, including potential mining tax overhauls and anti-mining protests that could disrupt operations. Technically the name sits in Weinstein stage 2. Factor exposures lean toward quality -2.13, growth +1.66, value +1.56. Research sentiment reads neutral. |
| NXE | 0.8% | NexGen Energy is a Canadian uranium exploration and development company focused on the Rook I project.. |
| CCJ | 0.8% | Bull case: The strongest bull case hinges on the accelerating AI data center power buildout and Cameco's strategic downstream integration. Recent catalysts include Cameco's June 2026 move to increase its stake in the tier-one Cigar Lake mine to 57.4%, alongside Westinghouse (49% owned by Cameco) securing a central role in an $80 billion U.S. government partnership to deploy AP1000 reactors. Analysts are reiterating buys on the recent dip, citing long-term uranium contract prices hitting $90/lb in Q1 2026, the highest level since 2008, which structurally insulates the company from spot market volatility. Bear case: The bear case focuses on severe valuation overhang and near-term execution friction. Trading at over 90x trailing earnings, the stock is highly vulnerable to multiple compression if uranium spot prices stall or if AI capex digestion delays actual reactor deployments. Furthermore, recent supply chain disruptions, such as the May 2026 bridge collapse in northern Saskatchewan that temporarily halted Key Lake and McArthur River supply lines, highlight the operational fragility of remote mining assets. Key risks include Severe valuation overhang leaving no margin of safety if uranium prices plateau or hyperscaler nuclear timelines slip.; Operational and supply chain disruptions at key Saskatchewan mines, as evidenced by recent infrastructure washouts. Research sentiment reads strong_buy. |
| COPX | 0.6% | Held as a critical_materials_defense sleeve constituent, sleeve rationale: Per critical_materials sleeve target (10%, data partial). It is positioned against a elevated credit regime, with high-yield credit spreads near 3.18%. |
| URA | 0.5% | Held as a critical_materials_defense sleeve constituent, sleeve rationale: Per critical_materials sleeve target (10%, data partial). It is positioned against a elevated credit regime, with high-yield credit spreads near 3.18%. |
| URNM | 0.3% | Held as a critical_materials_defense sleeve constituent, sleeve rationale: Per critical_materials sleeve target (10%, data partial). It is positioned against a elevated credit regime, with high-yield credit spreads near 3.18%. |
| NTR | 0.3% | Nutrien is a crop nutrient supplier with scale cost advantage from North American assets. Technically the name sits in Weinstein stage 2. Factor exposures lean toward quality -0.67, value +0.62, growth -0.22. Research sentiment reads neutral. |
| CF | 0.2% | Bull case: The strongest bull case rests on a "tighter for longer" nitrogen market combined with sharply bullish analyst revision flow. With Middle Eastern supply offline and European natural gas prices spiking, CF's North American cost advantage is generating massive free cash flow. This dynamic has triggered a powerful R19-T10 bullish revision-momentum signal, with consensus FY2026 EPS estimates surging over 70% in the last 60 days, while the Trump administration's recent permitting boost for CF's Blue Point low-carbon ammonia project adds a durable clean-energy growth vector. Bear case: The bear case argues that CF's recent 50%+ YTD rally has fully priced in the geopolitical premium, leaving the stock highly vulnerable to a sudden de-escalation in the Middle East. If the Strait of Hormuz reopens and Middle Eastern capacity floods back into the market, global nitrogen prices will crater, rapidly compressing CF's currently inflated margins and triggering a cyclical mean-reversion selloff. Key risks include Geopolitical de-escalation in the Middle East rapidly normalizing global nitrogen supply.; Cyclical mean-reversion risk following a massive 50%+ YTD rally. Technically the name sits in Weinstein stage 2. Factor exposures lean toward quality -2.18, low vol +0.86, value +0.47. Research sentiment reads neutral. |
| SQM | 0.1% | Chilean producer of specialty plant nutrients, iodine, and lithium chemicals with volatile commodity prices.. |
| ICL | 0.1% | ICL Group mines specialty minerals for agriculture and industrial uses, facing concession and commodity risks.. |
| ET | 0.0% | Midstream energy company operating pipelines and storage with commodity and regulatory risks.. |
Allocated: 100.0% across 22 model positions; the residual is the model's cash or unallocated sleeve.
Track Record
The track record below is measured from recommendations logged on or after 21 August 2026 and scored when each horizon matured, with every evaluated idea counted rather than a selected subset. Across that window the model portfolio is down 4.48% over 48 trading days, roughly in line with a daily-rebalanced 60/40 blend, while per-pick alpha has been negative at every horizon measured so far, shallow over one day, wider as the horizon lengthens. The sample is thin and clearly not long enough to carry much weight, and the record says so plainly: calls are written down before the outcome is known, then scored whether or not the result flatters the process. The 3-month horizon is still maturing, with first outcomes due from around 20 November 2026.
MODEL PORTFOLIO TOTAL RETURN since 2026-08-21 (as of 2026-10-28, 48 trading days): -4.48% vs 60/40 (SPY/AGG, daily-rebalanced) -0.07% (-4.41% relative). HYPOTHETICAL / MODEL portfolio performance — NOT an individual's actual account return; past performance does not guarantee future results.
Per-pick alpha (secondary skill metric):
Aggregate realized outcomes across model recommendations (proposed picks + manual recs) since 2026-08-21 (69 days of evaluated ideas) (every evaluated idea counted, not a cherry-picked subset):
1d horizon (n=428): hit rate 36% (share with positive alpha) · mean alpha -0.4% · mean raw return -0.3%
1w horizon (n=374): hit rate 41% (share with positive alpha) · mean alpha -0.9% · mean raw return -0.8%
4w horizon (n=107): hit rate 21% (share with positive alpha) · mean alpha -3.1% · mean raw return -2.0%
3m horizon: maturing — first outcomes from ~2026-11-20
DISCLAIMER — NOT INVESTMENT ADVICE (DECISION-LINKED)
This publication provides GENERAL and IMPERSONAL commentary and analysis on a regular schedule. The same content is provided to every subscriber. It is NOT investment advice, is NOT tailored to any individual, and does NOT account for your personal financial situation, objectives, or risk tolerance.
This post reports (1) a rules-based MODEL portfolio — target weights produced by an automated system's published rules, identical for all readers — and (2) DECISION-LINKED activity: how that affiliated automated system actually implemented, or has queued to implement, those rules in accounts belonging to the publication's operator. Model weights are not an account statement; the decision-linked positions and pending orders are REAL and belong to accounts affiliated with this publication's operator. We publish them for transparency on a fixed schedule under our Trading & Publication Policy [link] — not as a recommendation that any security or strategy is suitable for you. Because the publisher and/or operator hold or intend to establish positions in the securities discussed, a conflict of interest exists and our interests may differ from yours.
Nothing here is a recommendation to buy, sell, or hold any security for you specifically. Investing involves risk, including loss of principal. Past performance — model or actual — does not guarantee future results.
[Publisher LLC] is not a registered investment adviser and does not provide individualized investment advice. Consult a licensed professional before making any investment decision. See full disclosures, methodology, and our Trading & Publication Policy at [link].
POSITIONS DISCLOSURE: this is a hypothetical, rules-based model portfolio, not a statement of any individual's actual account; the publisher and/or author may hold positions in one or more of the securities listed.
CONFLICT OF INTEREST: because the publisher and/or author may hold listed securities, a conflict of interest exists and could benefit from price movements; the publisher receives no compensation for featuring any security, and this impersonal model illustration is not personalized investment advice or a solicitation to transact.
MICRO-CAP CAVEAT: some listed names are micro-capitalization securities held at small model weights; micro-caps carry elevated liquidity and volatility risk and are unsuitable for short-term trading — the small weights reflect that risk, and nothing here is a recommendation to scalp or rapidly trade thinly-traded securities.
Intended transactions: the affiliated automated system has open or queued target allocations in the following securities discussed here: SPY. These are real pending orders or model target weights in accounts belonging to the publication's operator, disclosed for transparency under our Trading & Publication Policy [link] — not a recommendation, and our interests may differ from yours.
Positions held: the publisher and/or operator currently holds positions in the following securities discussed here: CCJ, CF, COPX, ET, FCX, GDX, IAU, ICL, KMI, LDOS, LTPZ, NTR, NXE, QUAL, SCCO, SCHP, SQM, URA, URNM, VTIP.